Rockefeller Reforms Passed By New York State Senate

Voting on the reforms to the Rockefeller Drug Laws was initially delayed by illness; Senator Ruth Hassel-Thompson was taken ill on Wednesday (Senator Hassel-Thompson attended the New Directions for New York conference in January, sponsored by the New York Academy of Medicine, so her vote for the reforms could have been considered safe). Despite this turn, the state senate approved serious reforms to the Rockefeller Drug Laws as part of the state budget by a 32-30 vote margin. Leading the debates in favor of the reform was Senator Eric Schneiderman.

The DPA has created an automated feature to thank senators; please consider sending a quick message of appreciation.